On 10 June 2024 ICARST, n. o. officially received a certificate of competence to carry out research and development from the Ministry of Education, Research, Development and Youth of the Slovak Republic for the next 6 years, which proves the high level of research carried out in the period since its inception.
News
The paper entitled "Laccases as effective tools in the removal of pharmaceutical products from the aquatic systems" summarizes the recent progress in the field and it has been published as as a cooperative effort of the team of experts from the Faculty of Natural Sciences UCM, and ICARST.
The paper entitled "Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis" summarized the results of joint cooperative effort of ICARST with Faculty of Pharmacy UK, Bratislava, Faculty of Natural Sciences UCM, Trnava, Slovak Academy of Sciences...
On October 25 – 27, 2023 representatives of MAGI Research center lead by Dr. Matteo Bertelli, president of MAGI group, visited scientific institutions in Bratislava and Trnava tightly collaborating with ICARST. On October 26 several meetings were held at Faculty of Pharmacy UK, Institute of Chemistry and Institute of Molecular Biology SAS in...
The EUROBIOTECH 2023 has ended.
On October 4 - 6, 2023, the European Biotechnology Congress EUROBIOTEC 2023 (https://eurobiotech2023.org) was held in Ljubljana, Slovenia, where, at the invitation of the organizers, Prof. Stanislav Miertus delivered one of the plenary lectures on "Multidisciplinary Approach in Medicinal Biotechnology and its Application in the Research of...
The project was coordinated by Faculty of Pharmacy Comenius University in Bratislava and ICARST was one of the partners in the project.
The EUROBIOTECH 2022 has ended.
On October 5, 2022 - October 7, 2022, the European Biotechnology Congress EUROBIOTEC 2022 (www.eurobiotech.eu) was held in Prague, where, at the invitation of the organizers, Prof. Stanislav Miertus delivered one of the plenary lectures on "Developments in the Multidisciplinary Approach in Pharma" on October 5, 2022 and Medicinal Biotechnology: The...
The project AVIFLU "Computational Design, Synthesis, Testing and Disposition of Inhibitors of Neuraminidazes of Influenza A Virus as Potential Antiviral Compounds" has entered in the final months of its implementation. ICARST has contributed to the project by development of new methods of the determination of Neuraminidase inhibitory activity.
Professor S. Miertus, ICARST Director General, was a guest of the talkshow „Night Pyramid“
Professor S. Miertus, ICARST Director General, was a guest of the talkshow " Night Pyramid" of Slovak Radio SRo 1 talking about results of recent research in development of antiviral drugs and other issues.
ICARST, through its joint laboratory with University of SS. Cyril and Methodius (ICARST - UCM) has contributed to the results of the project. The project brought original results in a coordinated study of five partner laboratories specializing in computer-assisted drug design, bioavailability studies, drug synthesis, enzymatic and in vitro testing...
ICARST contributes through its join laboratories ICARST-Pharmaceutical Faculty, Commenius University, Bratislava and ICARST - University of SS. Cyril and Methodius, Trnava, to the APVV research project started on September 2020 entitled" New Antiviral Drugs: Design, Synthesis and Activity Evaluation of Specific Inhibitors of Viral Proteases of...